These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 28007586)
21. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Lewis DA; Volk DW; Hashimoto T Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885 [TBL] [Abstract][Full Text] [Related]
22. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Black JE; Kodish IM; Grossman AW; Klintsova AY; Orlovskaya D; Vostrikov V; Uranova N; Greenough WT Am J Psychiatry; 2004 Apr; 161(4):742-4. PubMed ID: 15056523 [TBL] [Abstract][Full Text] [Related]
23. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene. Kimoto S; Zaki MM; Bazmi HH; Lewis DA JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830 [TBL] [Abstract][Full Text] [Related]
24. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Volk DW; Lewis DA Neuroscience; 2013 Sep; 248():154-64. PubMed ID: 23769891 [TBL] [Abstract][Full Text] [Related]
25. Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Siegel BI; Sengupta EJ; Edelson JR; Lewis DA; Volk DW Biol Psychiatry; 2014 Jul; 76(2):160-7. PubMed ID: 24209773 [TBL] [Abstract][Full Text] [Related]
26. Prefrontal cortical circuits in schizophrenia. Volk DW; Lewis DA Curr Top Behav Neurosci; 2010; 4():485-508. PubMed ID: 21312410 [TBL] [Abstract][Full Text] [Related]
27. Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia. Datta D; Arion D; Roman KM; Volk DW; Lewis DA Am J Psychiatry; 2017 Feb; 174(2):163-171. PubMed ID: 27523502 [TBL] [Abstract][Full Text] [Related]
28. Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. Cruz DA; Eggan SM; Azmitia EC; Lewis DA Am J Psychiatry; 2004 Apr; 161(4):739-42. PubMed ID: 15056522 [TBL] [Abstract][Full Text] [Related]
29. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009 [TBL] [Abstract][Full Text] [Related]
30. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. Lewis DA; Cruz D; Eggan S; Erickson S Ann N Y Acad Sci; 2004 Jun; 1021():64-76. PubMed ID: 15251876 [TBL] [Abstract][Full Text] [Related]
31. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Volk DW; Lewis DA Curr Neuropharmacol; 2005 Jan; 3(1):45-62. PubMed ID: 22545031 [TBL] [Abstract][Full Text] [Related]
32. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia. Chung DW; Fish KN; Lewis DA Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795 [TBL] [Abstract][Full Text] [Related]
33. Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. Miguel-Hidalgo JJ; Dubey P; Shao Q; Stockmeier C; Rajkowska G Schizophr Res; 2005 Jul; 76(2-3):159-71. PubMed ID: 15949649 [TBL] [Abstract][Full Text] [Related]